MARSH & MCLENNAN COMPANIES, INC.·4

Feb 26, 4:43 PM ET

MCGIVNEY MARK C 4

4 · MARSH & MCLENNAN COMPANIES, INC. · Filed Feb 26, 2026

Research Summary

AI-generated summary of this filing

Updated

Marsh & McLennan (MRSH) CFO Mark McGivney Receives Equity Awards

What Happened
Mark C. McGivney, Chief Financial Officer of Marsh & McLennan Companies (MRSH), was granted equity awards on February 24, 2026 totaling 62,704 derivative shares: 44,743 stock options and 17,961 restricted stock units (resulting from performance stock units). Both grants show $0.00 per share (no cash purchase). The options vest in four equal annual installments (Feb 24 of 2027–2030); the restricted stock units reflect the payout of 2023–2025 performance stock units as of Feb 24, 2026.

Key Details

  • Transaction date: February 24, 2026; Form 4 filed Feb 26, 2026.
  • Grants: 44,743 options @ $0.00 (derivative); 17,961 RSUs/PSU conversion @ $0.00 (derivative). Total granted = 62,704 shares.
  • Vesting: Options vest in four equal annual installments on Feb 24 of 2027, 2028, 2029 and 2030 (Footnote F1).
  • Conversion: The RSUs/PSU payout converts to common stock on a 1-for-1 basis (F2); these RSUs reflect performance PSUs granted Feb 23, 2023 for the 2023–2025 period, with the performance factor determined Feb 24, 2026 (F3).
  • Tax withholding / other: Footnote F4: Not applicable.
  • Shares owned after transaction: Not specified in this Form 4.
  • Timeliness: Form reports transactions dated Feb 24, 2026 and was filed Feb 26, 2026 (no late-filing flag shown in the filing details provided).

Context
These entries are grants/award-related derivative transactions (options and performance-linked RSUs), not open-market purchases or sales. Grants are compensation and long-term incentives and do not represent an immediate cash outlay or sale of shares; they typically vest over time or convert based on performance. Retail investors should view awards as part of executive compensation rather than direct insider buying or selling.

Insider Transaction Report

Form 4
Period: 2026-02-24
MCGIVNEY MARK C
Chief Financial Officer
Transactions
  • Award

    Stock Options (Right to Buy)

    [F1]
    2026-02-24+44,74344,743 total
    Exercise: $176.99Exp: 2036-02-23Common Stock (44,743 underlying)
  • Award

    Restricted Stock Units

    [F2][F3][F4]
    2026-02-24+17,96117,961 total
    Common Stock (17,961 underlying)
Footnotes (4)
  • [F1]These options were granted on February 24, 2026 and vest in four equal annual installments on February 24th of 2027, 2028, 2029 and 2030.
  • [F2]The security converts to Marsh & McLennan Companies common stock on a 1-for-1 basis.
  • [F3]These restricted stock units relate to performance stock units that were granted on February 23, 2023 for the performance period 2023-2025. The performance factor for these performance stock units was determined on February 24, 2026.
  • [F4]Not Applicable
Signature
/s/ Tessa Patti, Attorney-in-fact|2026-02-26

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT